Website
News25/Ratings0
News · 26 weeks18-100%
2025-10-262026-04-19
Mix690d
- Earnings2(33%)
- SEC Filings2(33%)
- Insider2(33%)
Latest news
25 items- SECSEC Form 10-K filed by Ultralife Corporation10-K - ULTRALIFE CORP (0000875657) (Filer)
- INSIDERDirector Whitmore Bradford T bought $1,196,909 worth of shares (187,512 units at $6.38) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERPresident and CEO Manna Michael Edward bought $12,024 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.01), increasing direct ownership by 8% to 26,874 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Fourth Quarter ResultsNEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarterGross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarterOperating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarterGAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net
- PRUltralife Corporation to Report Fourth Quarter Results on March 10, 2026NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday, March 10, 2026. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on March 10, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIf9df949a927a4356820e8cfb1becccdc.
- INSIDERSEC Form 4 filed by Director Whitmore Bradford T4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Whitmore Bradford T bought $300,902 worth of shares (53,000 units at $5.68) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Goddard Janie bought $9,999 worth of Common Stock; $.10 par value (1,739 units at $5.75), increasing direct ownership by 29% to 7,668 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Robert W. Shaw bought $9,922 worth of Common Stock; $.10 par value (1,750 units at $5.67), increasing direct ownership by 3% to 71,000 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERDirector Whitmore Bradford T bought $267,915 worth of shares (53,900 units at $4.97) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- INSIDERPresident and CEO Manna Michael Edward bought $9,933 worth of Common Stock; $.10 par value (2,000 units at $4.97), increasing direct ownership by 9% to 24,874 units (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Third Quarter ResultsNEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1 million, including a $.5 million provision to close our Calgary facility, compared to operating income of $0.5 million for the third quarter of 2024GAAP EP
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation to Report Third Quarter Results on November 18, 2025NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI0301fd92021249ef830e0c9c7b
- PRUltralife Corporation Files Form 12b-25 Notification of Late FilingNEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025. As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. ("Electrochem") from Integer Holdings Corporation ("Integer"). During the third quarter of 2025, the transition services agreement between Ultralife and Integer under which Integer maintained the books and records of Electrochem on its information systems concluded, and
- SECSEC Form NT 10-Q filed by Ultralife CorporationNT 10-Q - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Receives Award for Its BA-5390 Military Batteries from U.S. Defense Logistics AgencyNEWARK, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) has received an award valued at approximately $5.2 million from the U.S. Government's Defense Logistics Agency ("DLA") for its lithium manganese dioxide, non-rechargeable BA-5390 military batteries. The majority of the shipments are scheduled throughout 2026 with completion in early 2027. "Ultralife has been a long-standing supplier to the U.S. military, and our BA-5390 battery remains recognized for its long life, unsurpassed safety record and reliability under the toughest conditions. We are pleased that DLA continues to select Ultralife. We received our last significant BA-5390 award from DLA in 2021.
- SECUltralife Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- INSIDERDirector Whitmore Bradford T bought $387,100 worth of shares (58,664 units at $6.60) (SEC Form 4)4 - ULTRALIFE CORP (0000875657) (Issuer)
- SECSEC Form 10-Q filed by Ultralife Corporation10-Q - ULTRALIFE CORP (0000875657) (Filer)
- SECUltralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ULTRALIFE CORP (0000875657) (Filer)
- PRUltralife Corporation Reports Second Quarter ResultsNEWARK, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the second quarter ended June 30, 2025 with the following results: Sales of $48.6 million increased 13.0% from $43.0 million for the second quarter of 2024; excluding Electrochem, sales of $39.3 million declined 8.7% due to a 57.2% decrease in Communications Systems salesGross profit of $11.6 million, or 23.9% of revenue, compared to $11.6 million, or 26.9% of revenue, for the second quarter of 2024Operating income of $2.3 million, including one-time non-recurring costs and purchase accounting adjustments of $0.3 million, compared to $3.9 million for the second quarter of 202
- PRUltralife Corporation to Report Second Quarter Results on August 7, 2025NEWARK, N.Y., July 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its second quarter results for the period ended June 30, 2025 before the market opens on Thursday, August 7, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at Noon ET on August 7, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIbda86e3ea7b342b6944287e49c2d3e9c. Th